Stakeholder views in pharmacogenetic testing

• Research type

  Research Study

• Full title

  A pilot study to investigate stakeholder views in pharmacogenetic testing as an aid to clinical decision making in treatment with clozapine in schizophrenia.

• IRAS ID

  119683

• Contact name

  Sarah Curran

• Contact email

  sarah.curran@kcl.ac.uk

• Sponsor organisation

  Kings College London, Institute of Psychiatry

• REC name

  London - Central Research Ethics Committee

• REC reference

  13/LO/0377

• Date of REC Opinion

  3 Apr 2013

• REC opinion

  Favourable Opinion